Home » Topics » BioWorld Science

BioWorld Science
RSS

Verbal memory reported to improve with raloxifene in postmenopausal women with AD

July 23, 2004

Dronabinol improves agitation in AD patients

July 23, 2004

Oxcarbazepine found safe and effective in reducing hypersexuality in male AD patients

July 23, 2004

Kahalalide F enters phase II trials in NSCLC and melanoma

July 23, 2004

Vical's DNA vaccine for anthrax tested in phase I study

July 23, 2004

Tentative approval for Cipher's CIP-Fenofibrate

July 23, 2004

Imvamune receives fast track designation

July 23, 2004

Juvaris BioTherapeutics in collaborative research agreement with Cell Genesys

July 23, 2004

Extension of Neuro3d's research collaboration with Johnson & Johnson

July 23, 2004

Roche seeks U.S. and E.U. approval for Pegasys in hepatitis B

July 23, 2004

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 29, 2026.
ENCALS 2026: From genetics to advancing strategies against ALS
BioWorld Science
Amyotrophic lateral sclerosis (ALS)-associated genes provide direct therapeutic targets and reveal pathways that can be used to develop treatments that counteract...
Next wave of BCI firms builds on pioneers to tackle challenges
BioWorld
With the pace of neurotechnology development accelerating, a wave of brain-computer interface (BCI) companies is emerging on the heels of the pioneers. In the...
Boehringer Ingelheim identifies new mGlu3 receptor agonists
BioWorld Science
Boehringer Ingelheim Pharma GmbH & Co. KG and Vanderbilt University have discovered new dihydrobenzoxazine compounds acting as metabotropic glutamate mGlu3...
GT-02897 exerts efficacy in preclinical multiple myeloma
BioWorld Science
Investigators from the Karl Landsteiner University aimed to evaluate the therapeutic potential of a novel CDK9 inhibitor/degrader, GT-02897, for the potential...